Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study

被引:0
|
作者
F Mouriaux
V Servois
J J Parienti
T Lesimple
A Thyss
C Dutriaux
E M Neidhart-Berard
N Penel
C Delcambre
L Peyro Saint Paul
A D Pham
N Heutte
S Piperno-Neumann
F Joly
机构
[1] CHU Rennes,Service d’ophtalmologie (Department of Ophthalmology)
[2] Faculté de Médecine (Faculty of Medicine),Département d’Imagerie Médicale (Curie Institute, Department of Medical Imaging)
[3] Université de Rennes 1,Service Dermatologie (Dermatology Department)
[4] Centre universitaire d’ophtalmologie-Recherche (Ophthalmology-Research University Centre),Département d’Oncologie Médicale, (Department of Medical Oncology
[5] Hôpital du Saint-Sacrement,undefined
[6] Centre de Recherche du CHU de Québec (CHU Quebec Research Centre),undefined
[7] CHU Caen,undefined
[8] Institut Curie,undefined
[9] Centre Eugène Marquis,undefined
[10] Centre Antoine Lacassagne,undefined
[11] CHU de Bordeaux,undefined
[12] Centre Léon Bérard,undefined
[13] Centre Oscar Lambret,undefined
[14] Centre François Baclesse,undefined
[15] Institut Curie,undefined
[16] Curie Institute),undefined
来源
British Journal of Cancer | 2016年 / 115卷
关键词
uveal; melanoma; eye metastasis; targeted therapy; quality of life; survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:20 / 24
页数:4
相关论文
共 50 条
  • [21] Relationship between physician-adjudicated adverse events (AE) and patient-reported health-related quality of life (HRQoL) in a phase II clinical trial of patients (pts) with metastatic uveal melanoma (UM).
    Atkinson, Thomas Michael
    Hay, Jennifer L.
    Doyle, L. Austin
    Paucar, Daniel
    Smith, Sloane C.
    Li, Yuelin
    Carvajal, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [22] Impact of sorafenib on health-related quality of life in Japanese patients with metastatic renal cell carcinoma: a prospective evaluation
    Miyake, Hideaki
    Kurahashi, Toshifumi
    Yamanaka, Kazuki
    Kondo, Yutaka
    Takenaka, Atsushi
    Inoue, Taka-aki
    Fujisawa, Masato
    BJU INTERNATIONAL, 2010, 106 (11) : 1643 - 1647
  • [23] O-mel-sora: A national multicenter phase II trial of sorafenib in metastatic uveal melanoma.
    Mouriaux, Frederic
    Servois, Vincent
    Piperno-Neumann, Sophie
    Lesimple, Thierry
    Thyss, Antoine
    Jouary, Thomas
    Neidhardt, Eve-Marie
    Panel, Nicolas
    Delcambre, Corinne
    Parienti, Jean-Jacques
    Serre-Henry, Caroline
    Joly, Florence
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Phase I/II study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma
    Kim, K. B.
    Davies, M. A.
    Papadopoulos, N. E.
    Bedikian, A. Y.
    Hwu, W.
    Woodard, K.
    Washington, E. W.
    Dancey, J. E.
    Wright, J.
    Hwu, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] A systematic review of health-related quality of life in cutaneous melanoma
    Cornish, D.
    Holterhues, C.
    van de Poll-Franse, L. V.
    Coebergh, J. W.
    Nijsten, T.
    ANNALS OF ONCOLOGY, 2009, 20 : 51 - 58
  • [26] Health-related quality of life in patients with metastatic pancreatic cancer
    Picozzi, V.
    Narayanan, S.
    Kayitalire, L.
    Hu, X. H.
    Vacirca, J.
    ANNALS OF ONCOLOGY, 2016, 27 : 53 - 53
  • [27] Health-Related Quality of Life in Patients with MPS II
    Needham, Mary
    Packman, Wendy
    Quinn, Natasha
    Rappoport, Maxwell
    Aoki, Christa
    Bostrom, Alan
    Cordova, Matthew
    Macias, Sandra
    Morgan, Cynthia
    Packman, Seymour
    JOURNAL OF GENETIC COUNSELING, 2015, 24 (04) : 635 - 644
  • [28] Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer
    Picozzi V.
    Narayanan S.
    Henry Hu X.
    Vacirca J.
    Journal of Gastrointestinal Cancer, 2017, 48 (1) : 103 - 109
  • [29] Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema
    Gjorup, Caroline A.
    Groenvold, Mogens
    Hendel, Helle W.
    Dahlstroem, Karin
    Drzewiecki, Krzysztof T.
    Klausen, Tobias W.
    Holmich, Lisbet R.
    EUROPEAN JOURNAL OF CANCER, 2017, 85 : 122 - 132
  • [30] Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512
    Bhatia, Shailender
    Moon, James
    Margolin, Kim A.
    Weber, Jeffrey S.
    Lao, Christopher D.
    Othus, Megan
    Aparicio, Ana M.
    Ribas, Antoni
    Sondak, Vernon K.
    PLOS ONE, 2012, 7 (11):